The overall goal of this proposal is to investigate the mechanism of NTF2-mediated Ran import. The Ran GTPase is a central component of an essential process in all eukaryotic cells -- nuclear transport. Results from this laboratory and others demonstrate that nuclear import of the small GTPase Ran is mediated by Nuclear Transport Factor 2 (NTF2), defining a novel Ran import pathway. Here, we will test three hypotheses based on our model for Ran import. Using in vitro biochemistry and a permeabilized cell assay, we will investigate the effect on Ran import of NTF2 sequestration and targeting of RanGDP to the nuclear pores. Additionally, we will test the prediction that RCC1 exchange activity is required for release of Ran from nuclear pores using quantitative exchange assays and a novel permeabilized cell assay. Finally, we will investigate the function in Ran transport of Nup 153, a candidate NTF2:RanGDP nuclear pore docking protein that is proposed to function in other transport pathways. Investigation of these hypotheses is likely to reveal new information as to the molecular interactions required for NTF2-mediated Ran transport, both in the soluble phase of transport and in the stationary phase at the nuclear pore. These new data may provide information critical to our further understanding of nuclear transport, a dynamic process absolutely required for life in all eukaryotic cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31GM020438-02
Application #
6342760
Study Section
Special Emphasis Panel (ZRG1-ALTX-4 (03))
Program Officer
Toliver, Adolphus
Project Start
2001-01-01
Project End
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
2
Fiscal Year
2001
Total Cost
$20,250
Indirect Cost
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904